Buy Itraconazole

Itraconazole

Itraconazole: Generic Medication Overview

Itraconazole is an antifungal medication approved for oral use in a variety of systemic and topical fungal infections. It belongs to the triazole class of antifungals and is available in capsule form (caps) in strengths of 100 mg and 200 mg. In Hong Kong, itraconazole is classified as a prescription-only (Rx) medicine and is regulated by the Department of Health’s Pharmacy and Poisons Board.

How Itraconazole Works in the Body

Itraconazole inhibits the fungal enzyme lanosterol 14α-demethylase, a key step in the synthesis of ergosterol, an essential component of the fungal cell membrane. By blocking ergosterol production, the drug destabilizes the membrane, leading to increased permeability and ultimately fungal cell death or growth arrest.

• Onset of action: Therapeutic levels are typically reached within 2-3 days of consistent dosing.
• Peak plasma concentration: Occurs about 3-5 hours after an oral dose.
• Duration: The drug’s half-life ranges from 20-30 hours, allowing once-daily dosing for many indications.

The capsule formulation is designed for optimal absorption when taken with food, which enhances its bioavailability compared with the suspension form.

Conditions Treated by Itraconazole

FDA/EMA-approved (and Hong Kong-recognized) indications include:

• Dermatophyte infections (e.g., tinea corporis, tinea pedis) when oral therapy is required.
• Blastomycosis (pulmonary and disseminated forms).
• Histoplasmosis (particularly chronic pulmonary disease).
• Coccidioidomycosis (non-meningeal).
• Sporotrichosis (cutaneous and lymphocutaneous).

These infections are caused by susceptible fungi that rely on ergosterol for membrane integrity, making itraconazole an effective treatment option.

Evidence-Based Off-Label Uses

The following applications have been reported in peer-reviewed literature but are not approved by regulatory agencies for itraconazole. Off-label use requires careful medical supervision.

• Chromoblastomycosis - case series suggest benefit, particularly with prolonged 200 mg daily therapy.
• Paracoccidioidomycosis - limited observational data indicate itraconazole may be an alternative to sulfamethoxazole-trimethoprim.

Off-label use requires individualized risk assessment and close monitoring.

Who Should (Not) Use Itraconazole?

Absolute contraindications

• Known hypersensitivity to itraconazole or any triazole antifungal.
• Concurrent use of strong CYP3A4 inducers (e.g., rifampin, carbamazepine, St John’s wort) because they markedly reduce itraconazole exposure.

Relative contraindications

• Severe hepatic impairment (Child-Pugh C); dose reduction or alternative therapy advised.
• Congestive heart failure (NYHA class III/IV) due to risk of negative inotropic effects.

Special populations

• Pregnancy: Category C (risk not ruled out); should be avoided unless benefits outweigh risks.
• Breastfeeding: Itraconazole is excreted in breast milk; consider alternative therapy.
• Elderly: Start at lower end of dosing range and monitor liver function closely.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Nausea, abdominal discomfort, or dyspepsia (often mild).
• Headache.
• Fatigue or mild dizziness.

These effects are usually transient and improve with continued therapy or food intake.

Serious Adverse Events

• Hepatotoxicity (elevated ALT/AST, jaundice) - requires prompt laboratory monitoring.
• Congestive heart failure exacerbation - patients with existing heart disease should be evaluated before initiation.
• Severe hypersensitivity reactions (e.g., Stevens-Johnson syndrome) - seek immediate medical attention.

Drug Interactions

• Major: Co-administration with ketoconazole, simvastatin, lovastatin, or cisapride can lead to heightened plasma levels and toxicity.
• Moderate: Calcium channel blockers (e.g., amlodipine), benzodiazepines (e.g., midazolam), and certain antiretrovirals (e.g., protease inhibitors) may require dose adjustments.
• Mechanism: Most interactions arise from itraconazole’s potent inhibition of the CYP3A4 enzyme, affecting the metabolism of many drugs.

Food and Lifestyle Interactions

• Take capsules with a full meal or a snack containing some fat to enhance absorption.
• Avoid grapefruit juice, which can further increase itraconazole levels and risk toxicity.
• Alcohol does not directly interact but excessive intake can exacerbate liver strain.

Patients should provide a complete medication list, including over-the-counter products and herbal supplements, to their prescriber.

How to Take Itraconazole

• Standard dosing:

• 200 mg once daily for most systemic infections (e.g., blastomycosis, histoplasmosis).

• 100 mg twice daily for certain dermatophyte infections or when a lower daily total is desired.

• Special populations:

• Renal impairment: No dose adjustment needed unless on hemodialysis; capsule is not removed by dialysis.

• Hepatic impairment: Reduce dose by 50 % for mild to moderate dysfunction; avoid use in severe cases.

• Administration tips:

• Swallow capsules whole; do not crush or open them.

• Take with food to improve bioavailability.

• Store at room temperature, away from moisture and direct sunlight.

• Missed dose: Take the missed dose as soon as remembered if within 12 hours; otherwise, skip and continue the regular schedule. Do not double-dose.

• Overdose: Symptoms may include severe nausea, vomiting, abdominal pain, and hepatic dysfunction. Seek emergency medical care; supportive measures and monitoring are the mainstays of treatment.

• Discontinuation: Abrupt cessation is generally safe, but for prolonged therapy (≥3 months) a taper may be considered to avoid rebound fungal growth.

Monitoring and Follow-Up

• Baseline labs: Liver function tests (ALT, AST, bilirubin) before starting therapy.
• Periodic monitoring: Repeat LFTs every 2-4 weeks during the first three months, then every 2-3 months thereafter.
• Clinical assessment: Evaluate for signs of heart failure, skin rash, or gastrointestinal upset at each visit.

Storage and Handling

• Keep capsules in the original container, tightly closed.
• Store at 20-25 °C (68-77 °F); protect from excess heat and moisture.
• Do not use tablets past the printed expiration date.
• Dispose of unused medication according to local pharmaceutical waste guidelines or return to a pharmacy for safe disposal.

Medication-Specific Glossary

CYP3A4

An enzyme in the liver and intestines that metabolizes many drugs; itraconazole strongly inhibits this enzyme, leading to increased levels of co-administered medications.

Ergosterol

A sterol component of fungal cell membranes; inhibition of its synthesis is the primary antifungal mechanism of itraconazole.

Bioavailability

The proportion of the administered drug that reaches systemic circulation; food-enhanced intake improves itraconazole’s oral bioavailability.

QTc Prolongation

A lengthening of the heart’s electrical repolarization interval on an ECG; itraconazole can modestly prolong QTc, especially when combined with other QT-prolonging agents.

Medical Disclaimer

This article provides educational information about itraconazole and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.